Question 1

What are the potential benefits and risks of taking rosiglitazone compared to metformin or glyburide?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide clinical trial (NCT00279045). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my blood sugar levels be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide clinical trial (NCT00279045). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I do if I experience side effects from the medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide clinical trial (NCT00279045). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide clinical trial (NCT00279045). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide clinical trial (NCT00279045). Contact the study team or your healthcare provider for specific answers.

What this study is about